Puma Biotechnology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PBYI Nasdaq 2836 www.pumabiotechnology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Puma Biotechnology, Inc.

Puma Biotechnology Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 2:05 pm
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Aug 5th, 2026 3:00 pm
Earnings Preview: Puma Biotech (PBYI) Q2 Earnings Expected to Decline - Jul 30th, 2026 8:00 am
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results - Jul 23rd, 2026 2:10 pm
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why - Jun 11th, 2026 9:48 am
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings - May 14th, 2026 6:04 am
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00 - May 11th, 2026 7:04 am
Puma (PBYI) Q1 2026 Earnings Call Transcript - May 8th, 2026 2:14 pm
Puma Biotechnology Q1 Earnings Call Highlights - May 8th, 2026 1:12 pm
PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised - May 8th, 2026 10:03 am
Puma Biotechnology, Inc. Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates - May 7th, 2026 5:05 pm
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue? - Apr 8th, 2026 9:30 am